Weiyuan Wang
- Topics
- Cancer-related molecular mechanisms research (7 papers)RNA modifications and cancer (7 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Weiyuan Wang
61 papers receiving 871 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 530
- Cancer Research 247
- Oncology 213
- Pulmonary and Respiratory Medicine 120
- Immunology 107
Countries citing papers authored by Weiyuan Wang
This map shows the geographic impact of Weiyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyuan Wang more than expected).
Fields of papers citing papers by Weiyuan Wang
This network shows the impact of papers produced by Weiyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyuan Wang. The network helps show where Weiyuan Wang may publish in the future.
Co-authorship network of co-authors of Weiyuan Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Weiyuan Wang. A scholar is included among the top collaborators of Weiyuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyuan Wang. Weiyuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 18 | |
| 3 | 35 | |
| 4 | 18 | |
| 5 | 7 | |
| 6 | 9 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 35 | |
| 10 | 3 | |
| 11 | 9 | |
| 12 | 18 | |
| 13 | 55 | |
| 14 | 25 | |
| 15 | 12 | |
| 16 | 21 | |
| 17 | 14 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 5 |
About Weiyuan Wang
Weiyuan Wang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 880 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (7 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Cancer Research (247 citations), Oncology (213 citations) and Molecular Biology (530 citations). Weiyuan Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Songqing Fan, Hongjing Zang, Jiadi Luo, Qiuyuan Wen, Lina Xu, Shuzhou Chu, Yuting Zhan, Lingjiao Chen, Guiyuan Xie and Jinghe Li. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.